Evidence map›Paper›PMID 23339195›Full record

ArticleThe Journal of biological chemistry2013

The role of Drosophila heparan sulfate 6-O-endosulfatase in sulfation compensation.

Katsufumi Dejima, Adam Kleinschmit, Masahiko Takemura, Pui Yee Choi, Akiko Kinoshita-Toyoda, Hidenao Toyoda, Hiroshi Nakato

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Deciphering functional glycosaminoglycan motifs in development.Current opinion in structural biology · 2018
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katsufumi DejimaDepartment of Genetics, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Adam Kleinschmit
Masahiko Takemura
Pui Yee Choi
Akiko Kinoshita-Toyoda
Hidenao Toyoda
Hiroshi Nakato

Funding

Genetic Study of Heparan Sulfate Function in DevelopmentR01HD042769 · NICHD · UNIVERSITY OF MINNESOTA TWIN CITIES · PI NAKATO, HIROSHI · 2003 to 2013
$2.6M
NICHD NIH HHS R01 HD042769
6 · The paper itself

Abstract

The biosynthesis of heparan sulfate proteoglycans is tightly regulated by multiple feedback mechanisms, which support robust developmental systems. One of the regulatory network systems controlling heparan sulfate (HS) biosynthesis is sulfation compensation. A previous study using Drosophila HS 2-O- and 6-O-sulfotransferase (Hs2st and Hs6st) mutants showed that loss of sulfation at one position is compensated by increased sulfation at other positions, supporting normal FGF signaling. Here, we show that HS sulfation compensation rescues both Decapentaplegic and Wingless signaling, suggesting a universal role of this regulatory system in multiple pathways in Drosophila. Furthermore, we identified Sulf1, extracellular HS 6-O-endosulfatase, as a novel component of HS sulfation compensation. Simultaneous loss of Hs2st and Sulf1 led to 6-O-oversulfation, leading to patterning defects, overgrowth, and lethality. These phenotypes are caused at least partly by abnormal up-regulation of Hedgehog signaling. Thus, sulfation compensation depends on the coordinated activities of Hs2st, Hs6st, and Sulf1.

Indexed as

AnimalsBody PatterningDrosophila melanogasterDrosophila ProteinsFibroblast Growth FactorsSignal TransductionSulfatasesSulfotransferasesDrosophila ProteinsFibroblast Growth Factorsheparan-sulfate 2-sulfotransferaseheparan sulfate 6-O-sulfotransferaseSULF1 protein, DrosophilaSulfatasesSulfotransferases

Identifiers

PMID23339195
PMCPMC3585090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.